{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:48:23Z","timestamp":1792075703009,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.maturitas.2026.109121","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:12:46Z","timestamp":1789629166000},"page":"109121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Estradiol transdermal spray for menopausal symptom management: From RCT to real-world evidence"],"prefix":"10.1016","volume":"214","author":[{"given":"Angelica Lind\u00e9n","family":"Hirschberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Stute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"\u00c1guas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Fait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Polo-Kantola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Gobbi","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"R\u00e9zette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Hadji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2026.109121_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bpobgyn.2022.03.002","article-title":"Bone and heart health in menopause","volume":"81","author":"Nash","year":"2022","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.maturitas.2026.109121_bb0010","series-title":"Productivity Loss Related to Vasomotor Symptoms (VMS) during Menopausal Transition among Women in the Nordic, IHE Report","author":"Malmberg","year":"2024"},{"key":"10.1016\/j.maturitas.2026.109121_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2024.107983","article-title":"Menopause in the workplace: challenges, impact, and next steps","volume":"185","author":"Safwan","year":"2024","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.maturitas.2026.109121_bb0020","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/13697137.2025.2585487","article-title":"International menopause society (IMS) recommendations and key messages on women\u2019s midlife health and menopause","volume":"28","author":"Panay","year":"2025","journal-title":"Climacteric"},{"issue":"7","key":"10.1016\/j.maturitas.2026.109121_bb0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of the North American Menopause Society","volume":"29","author":"NAMS","year":"2022","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109121_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2022.04.008","article-title":"Menopause, wellbeing and health: a care pathway from the European menopause and Andropause society","volume":"163","author":"Lambrinoudaki","year":"2022","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.maturitas.2026.109121_bb0035","doi-asserted-by":"crossref","first-page":"G49","DOI":"10.1093\/ejendo\/lvaf206","article-title":"European society of endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause","volume":"193","author":"Lumsden","year":"2025","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109121_bb0040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00404-022-06457-9","article-title":"Care reality of menopausal women in Germany: healthcare research using quantitative (SHI claims data) and qualitative (survey) data collection","volume":"306","author":"Stute","year":"2022","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.maturitas.2026.109121_bb0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejogrb.2024.10.046","article-title":"A quality assessment and systematic review of clinical practice guidelines on hormone replacement therapy for menopause using the AGREE II instrument","volume":"303","author":"Roman","year":"2024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2026.109121_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.109121_bb0055","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2026.109121_bb0060","article-title":"Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial","volume":"387","author":"Johansson","year":"2024","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.maturitas.2026.109121_bb0065","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00404-020-05682-4","article-title":"Peri- and postmenopause-diagnosis and interventions interdisciplinary S3 guideline of the association of the scientific medical societies in Germany (AWMF 015\/062): short version","volume":"302","author":"Ortmann","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"10.1016\/j.maturitas.2026.109121_bb0070","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00404-021-06009-7","article-title":"Addendum to: peri- and postmenopause-diagnosis and interventions interdisciplinary S3 guideline of the association of the scientific medical societies in Germany (AWMF 015\/062): short version","volume":"303","author":"Ortmann","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"10.1016\/j.maturitas.2026.109121_bb0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/13697137.2024.2394950","article-title":"Menopause and MHT in 2024: addressing the key controversies - an international menopause society white paper","volume":"27","author":"Panay","year":"2024","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.109121_bb0080","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00404-022-06647-5","article-title":"Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review","volume":"307","author":"Goldstajn","year":"2023","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.maturitas.2026.109121_bb0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.maturitas.2018.08.009","article-title":"Menopause and diabetes: EMAS clinical guide","volume":"117","author":"Slopien","year":"2018","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.109121_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.srhc.2022.100807","article-title":"Swedish women\u2019s experiences of menopausal transition: a focus group study","volume":"35","author":"Lycke","year":"2023","journal-title":"Sex. Reprod. Healthc."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109121_bb0095","first-page":"248","article-title":"Satisfaction on the use of a transdermal spray containing 1.53 mg estradiol for the treatment of symptoms associated with menopause","volume":"1","author":"\u00c1guas","year":"2020","journal-title":"GREM Gynecol. Reprod. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.maturitas.2026.109121_bb0100","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1177\/0091270009339187","article-title":"Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women","volume":"49","author":"Morton","year":"2009","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109121_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/17455057.5.1.23","article-title":"Low-dose estradiol spray: a novel treatment for vasomotor instability in postmenopausal women","volume":"5","author":"Buster","year":"2009","journal-title":"Womens Health (Lond)"},{"issue":"10","key":"10.1016\/j.maturitas.2026.109121_bb0110","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1021\/js9800275","article-title":"Transdermal delivery of estradiol in postmenopausal women with a novel topical aerosol","volume":"87","author":"Morgan","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.maturitas.2026.109121_bb0115","series-title":"Lenzetto 1.53 mg\/spray, transdermal spray, solution","author":"E.M.C. (eMC)","year":"2025"},{"issue":"6","key":"10.1016\/j.maturitas.2026.109121_bb0120","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/AOG.0b013e318175d162","article-title":"Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial","volume":"111","author":"Buster","year":"2008","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.maturitas.2026.109121_bb0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/13697137.2018.1504916","article-title":"The use of estradiol metered-dose transdermal spray in clinical practice","volume":"21","author":"Fait","year":"2018","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.maturitas.2026.109121_bb0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/13697137.2024.2376185","article-title":"Use of an estradiol transdermal spray in women with menopausal symptoms: a non-interventional study","volume":"27","author":"Hadji","year":"2024","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.109121_bb0135","first-page":"1","article-title":"Transdermal estradiol spray in Nordic menopausal women: real-world patient outcomes","author":"Polo-Kantola","year":"2026","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.109121_bb0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.maturitas.2022.09.006","article-title":"Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: a European cross-sectional survey","volume":"167","author":"Nappi","year":"2023","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.maturitas.2026.109121_bb0145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/13697137.2024.2380363","article-title":"The musculoskeletal syndrome of menopause","volume":"27","author":"Wright","year":"2024","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.109121_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejogrb.2025.114552","article-title":"Pharmacological treatments for menopausal vasomotor symptoms: a systematic review and Bayesian network meta-analysis of efficacy and safety","volume":"312","author":"Oliveira Amador","year":"2025","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.maturitas.2026.109121_bb0155","article-title":"Transdermal hormonal therapy in menopause: current evidence and personalized approaches","volume":"18","author":"ihai","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.maturitas.2026.109121_bb0160","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/GME.0000000000002266","article-title":"Comparative estrogen exposure from compounded transdermal estradiol creams and Food and Drug Administration-approved transdermal estradiol gels and patches","volume":"30","author":"Newman","year":"2023","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109121_bb0165","series-title":"BMS Guide to Hormone Replacement Therapy (HRT): Principles and Practice","author":"British Menopause Society","year":"2026"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226002987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226002987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:41:37Z","timestamp":1792075297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512226002987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S0378512226002987"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109121","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estradiol transdermal spray for menopausal symptom management: From RCT to real-world evidence","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109121"}}